At what enterprise value was DIDACTIC acquired in 2024?

You can find the full valuation details of DIDACTIC on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of DIDACTIC when it was acquired by UI INVESTISSEMENT?

The exact EV/EBITDA multiple for DIDACTIC is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was DIDACTIC acquired by UI INVESTISSEMENT?

DIDACTIC was acquired by UI INVESTISSEMENT in 2024.

What was the revenue of DIDACTIC at the time of the deal?

The revenue of DIDACTIC at the time of the deal is estimated to be in the range of 50M - 100M EUR. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the DIDACTIC acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DIDACTIC deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cfnews.net/L-actualite/LBO/Operations/LBO-Quaternaire/Didactic-dope-par-un-LBO-quaternaire-510007

← DATABASE

Home Database Healthcare & PharmaDIDACTIC

12/2024

DIDACTIC acquired by UI INVESTISSEMENT

FRANCE Life Sciences / Medical Devices / Medical Consumables REV 50M - 100M EUR

Context

Didactic reorganized its shareholder base to accelerate its transformation into a European industrial leader. GENEO Capital Entrepreneur and UI Investissement acquired a majority stake, taking over from the previous sponsor. The transaction involves significant reinvestment from the President and his management team, alongside Bpifrance and MACSF.

DIDACTIC, which reported an EBITDA margin of in 2023, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 1967, Didactic is a leading French player in the design, manufacture, and distribution of medical devices, specifically dedicated to infectious risk management and perfusion. As the market leader in examination gloves and the number two player in medical hygiene in France, Didactic supplies over 4,000 clients, primarily public hospitals and private clinics.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
02/2025	EURAZEO / TURENNE CAPITAL / KURMA PARTNERS	GERMITEC	FRANCE	Medical Devices
01/2025	QUADRIVIO GROUP	MIR - MEDICAL INTERNATIONAL RESEARCH	ITALY	Diagnostic Equipment
12/2024	NEXTSTAGE / IK PARTNERS	EUROBIO SCIENTIFIC	FRANCE	Diagnostic Equipment
11/2024	NAXICAP PARTNERS	GLOBAL D	FRANCE	Implants & Prosthetics
10/2024	KKR / KREFELD	ANJAC BEAUTY & HEALTH	FRANCE	CDMO
10/2024	CLAYTON, DUBILIER & RICE (CD&R)	OPELLA	FRANCE	Generics / Labs
10/2024	BANSK GROUP	PETIQ	UNITED STATES	Animal Health
09/2024	AGILENT TECHNOLOGIES	BIOVECTRA	CANADA	CDMO
08/2024	RECURSION PHARMACEUTICALS	EXSCIENTIA	UNITED KINGDOM	R&D Biotech
08/2024	NORDSON CORPORATION	ATRION CORPORATION	UNITED STATES	Diagnostic Equipment

REFERENCES

Revenue range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DIDACTIC by UI INVESTISSEMENT are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: ui investissement